The US Department of Defense issued a report concerning its shipment of live anthrax vaccine and concluded:
"On May 29, 2015, due to the inadvertent shipment of live anthrax from a Department of Defense (DoD) laboratory, the Deputy Secretary of Defense (DSD) directed the Under Secretary of Defense (USD) for Acquisition, Technology & Logistics (AT&L) to conduct a 30-day review of the Department’s safety practices for generating and handling inactivated Bacillus anthracis (BA).